A review on hyponatremia associated with SSRIs, reboxetine and venlafaxine
- 1 January 2006
- journal article
- review article
- Published by Taylor & Francis Ltd in International Journal of Psychiatry in Clinical Practice
- Vol. 10 (1), 17-26
- https://doi.org/10.1080/13651500500410216
Abstract
Hyponatremia, defined as serum sodium below 135 mmol/l, is a potentially life-threatening condition and was shown to be more frequent in elderly and psychiatric patients. In the last years numerous case reports on SSRI- and venlafaxine-induced hyponatremia were published indicating a higher incidence than previously thought. Only few studies have been performed and the incidence reported varies widely from 4.6/1000 people to 25%. It is still unclear if any single SSRI shows a higher incidence of hyponatremia than the others. Some data suggest that venlafaxine may have a stronger association to hyponatremia than SSRIs. Risk factors include age, female sex, low body mass index, severe physical illness, history of former hyponatremia and co-medications known to induce hyponatremia, especially thiazide diuretics. Symptoms of hyponatremia are usually neuropsychiatric (e.g. restlessness, lethargy, cognitive impairment), and any worsening in psychiatric symptoms in patients with a corresponding risk-profile receiving SSRIs or venlafaxine should give cause to check serum electrolytes. Usually SSRI-induced hyponatremia occurs within approximately 30 days and is reported to improve after withdrawal of the drug. Further controlled studies to confirm the true incidence of hyponatremia due to SSRI or venlafaxine and to define predictors more precisely are needed.Keywords
This publication has 75 references indexed in Scilit:
- Selective serotonin re‐uptake inhibitors (SSRIs) and hyponatraemia in the elderlyInternational Journal of Geriatric Psychiatry, 2004
- HyponatremiaThe New England Journal of Medicine, 2000
- Selective serotonin reuptake inhibitors and neuroendocrine functionLife Sciences, 1999
- Adverse Reactions of Selective Serotonin Reuptake InhibitorsDrug Safety, 1999
- The Effect of Fluvoxamine on Serum Prolactin and Serum Sodium ConcentrationsJournal of Clinical Psychopharmacology, 1997
- Drug-Induced Syndrome of Inappropriate Antidiuretic Hormone SecretionDrugs & Aging, 1997
- Hyponatraemia and the Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Induced by Psychotropic DrugsDrug Safety, 1995
- Mechanisms of Altered Water Metabolism in Psychotic Patients with Polydipsia and HyponatremiaThe New England Journal of Medicine, 1988
- Osmotic Demyelination Syndrome Following Correction of HyponatremiaThe New England Journal of Medicine, 1986
- HYPONATRAEMIA IN THE ELDERLYAge and Ageing, 1983